benign liver tumors
Recently Published Documents


TOTAL DOCUMENTS

83
(FIVE YEARS 4)

H-INDEX

14
(FIVE YEARS 0)

2021 ◽  
Vol 13 (9) ◽  
pp. 1098-1106
Author(s):  
Ana Ostojic ◽  
Anna Mrzljak ◽  
Danko Mikulic

2021 ◽  
Vol 10 (4) ◽  
pp. 658
Author(s):  
Daniel Crawford ◽  
Sailen Naidu ◽  
Indravadan Patel ◽  
Grace Knuttinen ◽  
Sadeer Alzubaidi ◽  
...  

Transarterial embolization has shown promise as a safe, effective, and less invasive treatment modality for benign liver lesions (hemangioma, focal nodular hyperplasia (FNH), and hepatic adenoma (HA)) with fewer complications compared to surgical intervention. There is no consensus regarding the most appropriate embolization material(s) for the treatment of benign liver tumors. The purpose of this study was to review the current literature regarding the transarterial embolization of benign liver tumors and to share our single center experience. This was a non-blinded, retrospective, single-institution review of the bland embolization of benign liver tumors. Clinical data and imaging before and after embolization were used to evaluate lesion response to transarterial embolization. Twelve patients were included in the study. Five patients with six hemangiomas were treated. Pain was a presenting complaint in all five of these patients. The median change in tumor volume was −12.4% and ranged from −30.1% to +42.3%. One patient with two FNH lesions was treated, and both lesion volumes decreased by more than 50%. Six patients with 10 adenomas were treated. Pain was a presenting complaint in three patients, and five patients had a lesion >5 cm. The median change in tumor volume was −67.0% and ranged from −92.9% to +65.8%. Bland transarterial embolization of liver hemangiomas, FNH, and HA can be an effective and minimally invasive treatment modality to control the size and/or symptoms of these lesions. There is a variable response depending on tumor type and the embolization materials used.


Author(s):  
Pei-Li Fan ◽  
Yi Dong ◽  
Wen-Ping Wang ◽  
Jia-Ying Cao

Author(s):  
Jia-Ying Cao ◽  
Yi Dong ◽  
Wen-Ping Wang ◽  
Han-Sheng Xia ◽  
Pei-Li Fan

2020 ◽  
Vol 29 (4) ◽  
pp. 150941
Author(s):  
J. Fuchs ◽  
S.W. Warmann ◽  
C. Urla ◽  
J.F. Schäfer ◽  
A. Schmidt

2020 ◽  
pp. 1-12
Author(s):  
Jin Yin ◽  
Jia-Jun Qiu ◽  
Wei Qian ◽  
Lin Ji ◽  
Dan Yang ◽  
...  

2020 ◽  
Vol 36 (4) ◽  
pp. 292-303
Author(s):  
Karl J. Oldhafer ◽  
Victoria Habbel ◽  
Katja Horling ◽  
Georgios Makridis ◽  
Kim Caroline Wagner

2018 ◽  
Vol 40 (01) ◽  
pp. 12-29 ◽  
Author(s):  
Christoph Dietrich

AbstractThe diagnostic handling of benign focal liver lesions (FLLs) is a challenge and it is difficult to avoid over- and underdiagnosis. Conventional B-mode ultrasound and contrast-enhanced ultrasound (CEUS) are the first-line imaging methods to detect and characterize FLLs. This CME article discusses the diagnostic workup of benign liver tumors.


2018 ◽  
Vol 12 (3) ◽  
pp. 69-73
Author(s):  
Shane A. Wells ◽  
Timothy J. Ziemlewicz ◽  
Meghan G. Lubner

Sign in / Sign up

Export Citation Format

Share Document